Arkansas, Novo Nordisk Clash Over Court’s Role in Contract Pharmacy Law Enforcement

Novo Nordisk logo on building
Novo Nordisk and the Arkansas Insurance Department are at odds over whether a federal district court should intervene in the enforcement of Arkansas' 340B contract pharmacy law.
Novo Nordisk and the Arkansas Insurance Department (AID) are sparring in court over whether a federal district court should hear [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

N.Y. State, Health Centers Seek Brief Pause in Medicaid Drug Benefit Lawsuit

The parties involved in a legal challenge over certain Medicaid managed care drug benefits have jointly asked for a pause in proceedings.
Both sides in a lawsuit over New York state’s transfer of Medicaid managed care drug benefits to Medicaid fee for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Why the Genesis 340B Patient Definition Court Decision Could Resolve the Contract Pharmacy Impasse

Ted Slafsky, publisher and CEO of 340B Report, writes the second part of his two-part column on the Senate "group of six" 340B discussion draft.
In what legal experts describe as a landmark decision, the U.S. District Court for the District of South Carolina ruled [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Apexus Asks Appeals Court to Affirm Dismissal of Contract Breach Lawsuit

AHF has asked a federal appeals court to reverse an earlier court's decision to dismiss a case against Apexus over its provision of 340B sub-ceiling price discounts on drugs.
Apexus, the 340B prime vendor, asked a federal appeals court to affirm a lower court’s dismissal of claims that it [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Court Sets November 2024 Trial for Novo Nordisk’s Arkansas 340B Lawsuit

Novo Nordisk logo on building
Novo Nordisk and the Arkansas Insurance Department are at odds over whether a federal district court should intervene in the enforcement of Arkansas' 340B contract pharmacy law.
The trial for drugmaker Novo Nordisk’s legal challenge to Arkansas’ 340B contract pharmacy law will wait a year to commence. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Louisiana Provider Group to Intervene in Second 340B Contract Pharmacy Lawsuit

A federal district judge allowed the Louisiana Primary Care Association's to intervene in a second drug industry lawsuit challenging Louisiana's 340B contract pharmacy law.
A Louisiana provider group was allowed to support the state attorney general’s legal defense of Louisiana’s 340B contract pharmacy law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novo Nordisk’s 340B Arkansas Lawsuit Reassigned to Judge Who Previously Ruled Against Drugmakers

Novo Nordisk logo on building
Novo Nordisk and the Arkansas Insurance Department are at odds over whether a federal district court should intervene in the enforcement of Arkansas' 340B contract pharmacy law.
A federal district court transferred drugmaker Novo Nordisk’s lawsuit challenging Arkansas’ 340B contract pharmacy law to a judge who previously [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Louisiana Provider Group to Intervene in 340B Contract Pharmacy Lawsuit

A federal district judge allowed the Louisiana Primary Care Association's to intervene in a second drug industry lawsuit challenging Louisiana's 340B contract pharmacy law.
A federal judge allowed a Louisiana provider group to join the state attorney general in defending Louisiana’s 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genesis Ruling Could Expand 340B-Eligible Prescriptions, Say Some Attorneys

Kyle Vasquez, an attorney for Polsinelli, said the Genesis ruling was "limited in reach" but could create obstacles for other HRSA enforcement activity.
A recent ruling by a federal district judge in South Carolina potentially could expand 340B-eligible prescriptions, say some provider advisers. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Reinstates Tighter 340B Contract Pharmacy Restrictions

Lilly
Eli Lilly is conducting government approved 340B provider audits that for the first time look for certain Medicaid health plan duplicate discounts.
Pharmaceutical giant Eli Lilly this week announced it would reinstate tighter 340B contract pharmacy restrictions for all covered entity types. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live